Showing posts with label dasatinib. Show all posts
Showing posts with label dasatinib. Show all posts
Monday, July 11, 2011
Targeting Src in Mucinous Ovarian Carcinoma (dasatinib/oxaliplatin)
"Targeting src kinase with combination of dasatinib and oxaliplatin may be an attractive approach in this disease."
Subscribe to:
Comments
(
Atom
)
